OHIO spectrum as a proposed modified nomenclature for polycystic ovary syndrome

Conflict of interest statement

The authors declare no competing interests.

Funding

The study receives no extramural funding.

Authors’ contributions

All authors contributed equally in conceiving, drafting and preparing the manuscript.

Publisher’s Note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] Barik S, Faruque F. Etiological factors of irregular periods in young women in a semi urban tertiary care hospital of West Bengal, India. Indian J Perinatol Reprod Biol 2020; 10(2):60-63.

[2] Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries-A common finding in normal women. Lancet 1988; 1(8590):870-872.

[3] Murphy MK, Hall JE, Adams JM, Lee H, Welt CK. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91(10):38783884.

[4] Kristensen SL, Ramlau-Hansen CH, Ernst E, Olsen SF, Bonde JP, Vested A, et al. A very large proportion of young Danish women have polycystic ovaries: Is a revision of the Rotterdam criteria needed? Hum Reprod 2010; 25:3117-3122.

[5] Khadilkar S. Polycystic ovarian syndrome: Is it time to rename PCOS to HA-PODS? J Gynecol Obstet India 2016; 66:81-87.

[6] Rosenwaks Z. Polycystic ovary syndrome, an enigmatic syndrome begging for a name change. Fertil Steril 2017; 108:748-749.

[7] Bhattacharyya S, Barik S, Samashaptak, Saha S. Contemporary knowledge on the genetic basis of polycystic ovarian syndrome. JIMA 2023; 121(9):54-59.

[8] Bhattacharyya S, Barik S, Gupta S, Saha S, Goswami MM, Goswami U, et al. Metabolomics approach for the etiopathogenesis of polycystic ovarian syndrome. Natl J Physiol Pharm Pharmacol 2024; 14(6). doi: 10.5455/njppp.2024.14.04160202419042024.